Views & Analysis To PSP or not to PSP? That is NOT the question A practical guide to planning and running an effective patient support programme.
Views & Analysis Patient support: balancing technology with the human touch Tangible improvements can be seen in clinical outcomes and treatment satisfaction if patients are involved.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
